PHILADELPHIA – In contrast to amphibian tissue regeneration, traumatic injuries in mammals typically heal with a fibrous scar. Researchers discovered that some strains of mice heal without a scar, by disrupting a protein, called Sdf1, that normally recruits white blood cells to sites of injury. Blocking Sdf1 function with a drug or by mouse genetics enhanced tissue regeneration and decreased scarring in normal mice.
The team, led by former Stanford pediatric dermatologist Thomas Leung, MD, PhD, now an assistant professor in the Perelman School of Medicine at the University of Pennsylvania, studied how the ears of mice heal from a hole punched through the thin tissue (much like ear piercing in humans). In many strains of mice, the holes heal with a scar and remain visible. In a few others, the holes completely close without a perceptible scar.
They published their work in Genes and Development, and their findings may one day lead to advances in regenerative medicine.
Because the drug used to block Sdf1 signaling is already used in medical clinics to mobilize stem cells in transplant patients, Leung is hopeful that it can quickly be tested in humans struggling to heal chronic or slow-healing wounds. He is currently designing a clinical trial to test the drug, called AMD3100.
Additional details are available in a Stanford Medicine article.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.